Multiple Sclerosis, Relapsing-Remitting
"Multiple Sclerosis, Relapsing-Remitting" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The most common clinical variant of MULTIPLE SCLEROSIS, characterized by recurrent acute exacerbations of neurologic dysfunction followed by partial or complete recovery. Common clinical manifestations include loss of visual (see OPTIC NEURITIS), motor, sensory, or bladder function. Acute episodes of demyelination may occur at any site in the central nervous system, and commonly involve the optic nerves, spinal cord, brain stem, and cerebellum. (Adams et al., Principles of Neurology, 6th ed, pp903-914)
| Descriptor ID |
D020529
|
| MeSH Number(s) |
C10.114.375.500.600 C10.314.350.500.600 C20.111.258.250.500.600
|
| Concept/Terms |
Multiple Sclerosis, Relapsing-Remitting- Multiple Sclerosis, Relapsing-Remitting
- Multiple Sclerosis, Relapsing Remitting
- Remitting-Relapsing Multiple Sclerosis
- Multiple Sclerosis, Remitting-Relapsing
- Remitting Relapsing Multiple Sclerosis
- Relapsing-Remitting Multiple Sclerosis
- Relapsing Remitting Multiple Sclerosis
|
Below are MeSH descriptors whose meaning is more general than "Multiple Sclerosis, Relapsing-Remitting".
Below are MeSH descriptors whose meaning is more specific than "Multiple Sclerosis, Relapsing-Remitting".
This graph shows the total number of publications written about "Multiple Sclerosis, Relapsing-Remitting" by people in this website by year, and whether "Multiple Sclerosis, Relapsing-Remitting" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 1 | 2 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 4 | 0 | 4 |
| 2017 | 24 | 3 | 27 |
| 2018 | 32 | 3 | 35 |
| 2019 | 15 | 2 | 17 |
| 2020 | 10 | 0 | 10 |
| 2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Multiple Sclerosis, Relapsing-Remitting" by people in Profiles.
-
COVID-19 in Cladribine-treated patient with multiple sclerosis. J Neuroimmunol. 2021 10 15; 359:577690.
-
Chickenpox and asymptomatic COVID-19 after first cycle of alemtuzumab for multiple sclerosis. Neurol Sci. 2021 10; 42(10):4003-4005.
-
Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19. Neurol Neuroimmunol Neuroinflamm. 2021 09; 8(5).
-
MS and COVID-19 challenge: asymptomatic COVID-19 infection during treatment with cladribine. Neurol Sci. 2021 Sep; 42(9):3533-3535.
-
SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry. Neurol Neuroimmunol Neuroinflamm. 2021 07; 8(5).
-
SARS-CoV-2 infection and seroprevalence in patients with multiple sclerosis. Neurologia (Engl Ed). 2021 Nov-Dec; 36(9):698-703.
-
Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study. Mult Scler Relat Disord. 2021 08; 53:103054.
-
COVID-19 in Argentine teriflunomide-treated multiple sclerosis patients: First national case series. Mult Scler Relat Disord. 2021 Aug; 53:103049.
-
Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic? J Neurol Sci. 2021 08 15; 427:117501.
-
Unexpected worsening of progressive multifocal leucoencephalopathy following COVID-19 pneumonia. J Neurovirol. 2021 06; 27(3):510-513.